Researchers Question Safety of Mist Inhalers for Delivering Common Drug for Chronic Lung Disease
Johns Hopkins MedicinePeople who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease (COPD) may be 52 percent more likely to die, new Johns Hopkins-led research suggests.